Anticoagulation in the management of ST-segment elevation myocardial infarction

Paul P. Dobesh, Toby C. Trujillo

Research output: Contribution to journalReview articlepeer-review


Patients with ST-segment elevation myocardial infarction (STEMI) require immediate reperfusion therapy in order to salvage ischemic myocardial tissue and reduce mortality. Reperfusion therapy can be provided mechanically with primary percutaneous coronary intervention (PCI), or pharmacologically with fibrinolysis. Regardless of the reperfusion strategy selected, the appropriate use of anticoagulant therapy is critical to its success. There have been a number of clinical trials evaluating the different anticoagulants in patients with STEMI, as well as recent updates to the guidelines for management of patients with STEMI and on the use of PCI. When making clinical decisions on the use of anticoagulant therapy in the management of patients with STEMI, it is important to not only understand the contents of these consensus guidelines but to also have an appreciation of the details of the clinical trials that have evaluated the different anticoagulants. In this review, the reader will find an evaluation of the current guidelines concerning the use of anticoagulant therapy in patients with STEMI as well as a detailed examination of the literature with critical analysis on issues that should be considered when deciding on the appropriate implementation of anticoagulant therapy in patients with STEMI undergoing either mechanical or pharmacologic reperfusion.

Original languageEnglish (US)
Pages (from-to)335-343
Number of pages9
JournalJournal of Pharmacy Practice
Issue number4
StatePublished - Aug 2010


  • acute coronary syndrome
  • anticoagulation
  • bivalirudin
  • cardiology
  • coronary artery disease
  • enoxaparin
  • fibrinolysis
  • fondaparinux
  • low-molecular-weight heparin
  • myocardial infarction
  • percutaneous coronary intervention
  • unfractionated heparin

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Anticoagulation in the management of ST-segment elevation myocardial infarction'. Together they form a unique fingerprint.

Cite this